Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation. (Q52871467)

9 May 2018

title

Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation. (English)

1 reference

9 May 2018

author name string

Jones SC

1

1 reference

9 May 2018

Crabtree JE

2

1 reference

9 May 2018

Rembacken BJ

3

1 reference

9 May 2018

Dixon MF

4

1 reference

9 May 2018

Trejdosiewicz LK

5

1 reference

9 May 2018

Whicher JT

6

1 reference

9 May 2018

Axon AT

7

1 reference

9 May 2018

publication date

1 August 1994

1 reference

9 May 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

9 May 2018

volume

29

1 reference

9 May 2018

issue

8

1 reference

9 May 2018

page(s)

722-728

1 reference

9 May 2018

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Biological and clinical aspects of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Pharmacokinetics of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC class II (HLA-D) antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Transforming growth factor-beta enhances secretory component and major histocompatibility complex class I antigen expression on rat IEC-6 intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Interleukin 6/B cell stimulatory factor-II is expressed and released by normal and transformed human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Expression of interleukin-6 by intestinal enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Drug therapy of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Glucocorticoids inhibit the production of IL6 from monocytes, endothelial cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529409092500

10.3109/00365529409092500

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018